SCH 59761

Drug Profile

SCH 59761

Latest Information Update: 22 Feb 2000

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Schering-Plough
  • Class Antihypertensives
  • Mechanism of Action Adenosine A1 receptor agonists; Adenosine A2 receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Hypertension

Most Recent Events

  • 22 Feb 2000 No-Development-Reported for Hypertension in Italy (PO)
  • 25 Mar 1997 New profile
  • 25 Mar 1997 Preclinical development for Hypertension in Italy (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top